1. Home
  2. FEAM vs PYXS Comparison

FEAM vs PYXS Comparison

Compare FEAM & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$2.04

Market Cap

80.6M

Sector

Industrials

ML Signal

HOLD

Logo Pyxis Oncology Inc.

PYXS

Pyxis Oncology Inc.

HOLD

Current Price

$1.33

Market Cap

71.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
PYXS
Founded
2016
2018
Country
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.6M
71.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FEAM
PYXS
Price
$2.04
$1.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$8.13
$6.75
AVG Volume (30 Days)
566.6K
548.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$500.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.96
$0.83
52 Week High
$7.50
$5.55

Technical Indicators

Market Signals
Indicator
FEAM
PYXS
Relative Strength Index (RSI) 32.37 35.20
Support Level $2.11 $1.28
Resistance Level $2.59 $1.39
Average True Range (ATR) 0.33 0.12
MACD -0.00 0.02
Stochastic Oscillator 13.35 11.91

Price Performance

Historical Comparison
FEAM
PYXS

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: